Medical directors need to review protocols, especially if a patient doesn't respond after 4-6 weeks, side effects appear, or new regulations come up
Possible clinical applications for elevated glutathione levels Neurology Parkinsons disease Alzheimers disease Seizures Multiple sclerosis Eye diseases Cataracts Macular degeneration Glaucoma Cardiovascular Prevent heart disease Prevent stroke Prevent atherosclerosis Prevent reperfusion injury Digestive system Inflammatory bowel disease Hepatitis Malnutrition Pancreatitis Peptic Ulcer Toxicology Certain drug overdoses Tobacco smoke, auto exhaust Pollutants including heavy metals, pesticides Prevents hearing loss from noise pollution Detoxifies many well-known carcinomas Infectious disease and immunology Anti-viral (AIDS, hepatitis, herpes, common cold, etc.) Bacterial Infection Certain autoimmune dysfunction Chronic fatigue syndrome Immunosuppression Cancer Cancer prevention Suppress tumor growth Eliminate Carcinogens, mutagens Retard oxidative damage to DNA Prevent wasting disease Ease side effects of chemo- and radiotherapy Pulmonary Break up mucus (esp
BPC-157 is not one of them
[DOI] [PubMed] [Google Scholar] 6.Xin Y, Wang Y, Zhong L, Shi B, Liang H, Han J
Aiding in Pathogen Defense: In flu models, GPx1 reduces lung inflammation, enhancing recovery
